ENL
ENL
Enaleni Pharmaceuticals Limited - Trading update
Enaleni Pharmaceuticals Limited
(Incorporated in the Republic of South Africa)
(Registration number 2002/018027/06)
(JSE code: ENL & ISIN: ZAE000067740)
("Enaleni")
Trading update
Shareholders are referred to the circular dated 28 November 2005, which
contained the results for the six month period ended 30 June 2005, wherein
earnings per share ("EPS") was disclosed as 8.7 cents and headline earnings per
share ("HEPS") was disclosed as 4.3 cents. Shareholders are now advised that it
is expected that EPS for the period ended 30 June 2006 will be 45% - 55% higher
than the figures disclosed in the circular for the prior comparative period and
HEPS is expected to be 185% - 195% higher than the figures for the prior
comparative period.
The above information has not been reviewed by the company"s auditors and the
company"s interim results for the six months ended 30 June 2006 are expected to
be published on 28 August 2006.
11 August 2006
Sponsor
Nedbank Capital
Date: 11/08/2006 12:16:02 PM Produced by the JSE SENS Department
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
